Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-06

Clinical Trial Update: Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in Botswana comparing limited versus continuous isoniazid preventive therapy for tuberculosis prevention in HIV-infected individuals ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Tuberculosis, HIV Infections | Phase 4 | Status: COMPLETED